CRO Inks OmniComm EDC Agreement

A full-service CRO, with global clinical operations, has signed an agreement to use TrialMaster EDC from OmniComm Systems, Inc., a provider of clinical data management technology. Under the terms of the agreement, the CRO will use OmniComm’s TrialMaster for future studies, including an upcoming Phase Ib study on behalf of a sponsor based in the UK.

The CRO chose TrialMaster to complement an existing in-house EDC system and to provide additional support tools for more complex study designs. TrialMaster has built-in patient questionnaire capability, site experience for data collection and study build tools. OmniComm will provide the CRO with technology, training, study development, quality assurance and project management support.

"We are excited to have been selected as the organization’s EDC technology provider," said Kuno van der Post, Ph.D., chief commercial officer, OmniComm Systems. "To have another key CRO in Europe choose TrialMaster because of the very modern user interface and fast study build capability is very rewarding. The CRO team also appreciated the built-in ability to deploy patient questionnaires, which will be a key component for capturing data directly from patients in the initial study."

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.